HopeStage
Back to overview

Depression studies

Topics
More filters

Depression

Depression involves persistent low mood or loss of interest, often with tiredness and changes in sleep or appetite.

7264studies shown
Showing 2,353-2,364 of 7,264
Device study icon
TerminatedNCT05551195

Digital Therapeutic for depression

Official study title

A Multicenter, Randomized, Double-Blind, Controlled Study Evaluating the Efficacy and Safety of a Digital Therapeutic as an Adjunct to Treatment as Usual Among Women With Mild to Moderate Postpartum Depression

This study ended early.

Multiple locations, including Lafayette
DepressionDevice studyAges 22–45
Countries
United States
Sponsor
Woebot Health
Drug study icon
CompletedNCT03543410

A Clinical Study to Test the Effectiveness of an Investigational Drug to Treat People That Have Major Depressive Episodes When They Have Bipolar 1 Depression

What is this study about?

Researchers compared SEP-4199 200 mg, SEP-4199 400 mg and placebo to find out how the approaches affected depression symptoms in people with bipolarity type I during a depressive episode.

This study has finished and is no longer accepting participants.

Multiple locations, including Cerritos
Depression, BipolarityMedication studyAges 18–65
Countries
United States, Bulgaria, Japan, + 5 others
Sponsor
Sumitomo Pharma America, Inc.
Drug study icon
CompletedNCT03460756

A study of Oral Ganaxolone in Women With Postpartum Depression

What is this study about?

This study evaluated the safety and effectiveness of Ganaxolone for people with depression.

This study has finished and is no longer accepting participants.

Multiple locations, including Glendale
DepressionMedication studyAges 18–48
Countries
United States
Sponsor
Marinus Pharmaceuticals
Other study type icon
CompletedNCT07382336

A Mobile Application for Early Detection and Symptoms Trajectories of Postpartum Depression Using Ecological Momentary Assessment (EMA)

Official study title

A Mobile Application for Early Detection and Symptoms Trajectories of Postpartum Depression Using Ecological Momentary Assessment (EMA): A Prospective Cohort Validation Study

This study has finished and is no longer accepting participants.

In Hong Kong
DepressionObservational studyAges 18+
Countries
China
Sponsor
The Hong Kong Polytechnic University
Drug study icon
CompletedNCT05455684

Aticaprant for depression

What is this study about?

This study evaluated the safety and effectiveness of Aticaprant for people with depression.

This study has finished and is no longer accepting participants.

Multiple locations, including Tucson
DepressionMedication studyAges 18–74
Countries
United States, Australia, Belgium, + 10 others
Sponsor
Janssen Research & Development, LLC
Drug study icon
CompletedNCT06057012

BRII-296 in Adults With Severe Postpartum Depression (PPD)

What is this study about?

This study evaluated the safety and effectiveness of BRII-296 for people with depression.

This study has finished and is no longer accepting participants.

Multiple locations, including Sherman Oaks
DepressionMedication studyAges 18–45
Countries
United States
Sponsor
Brii Biosciences Limited
Drug study icon
CompletedNCT06285916

Safety study of Efficacy, Safety, and Tolerability of Oral NORA520 in depression

Official study title

A Randomized, Placebo-Controlled, Double-Blinded, Phase 2 Study to Evaluate the Efficacy, Safety, and Tolerability of Oral NORA520 in Female Adults With Severe Postpartum Depression

This study has finished and is no longer accepting participants.

Multiple locations, including Bentonville
DepressionMedication studyAges 18–45
Countries
United States
Sponsor
TWi Biotechnology, Inc.
Other study type icon
CompletedNCT04463108

A Study to Describe Routine Treatment Pathways in people with Major Depression and Active Suicide prevention With Intent in Italy

Official study title

A Description of Routine Treatment Pathways in a Cohort of Patients With Major Depression and "Active Suicidal Ideation With Intent" in Italy: the Arianna Observational Study.

This study has finished and is no longer accepting participants.

Multiple locations, including Brescia
Depression, SuicidalityObservational studyAges 18–74
Countries
Italy
Sponsor
Janssen-Cilag S.p.A.
Drug study icon
CompletedNCT02942004

SAGE-547 for depression

Official study title

A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression

This study has finished and is no longer accepting participants.

Multiple locations, including Chandler
DepressionMedication studyAges 18–45
Countries
United States
Sponsor
Supernus Pharmaceuticals, Inc. (Pharmaceutical company)

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.